{
  "variant_id": {
    "Gene": "PRC2 Complex Component (e.g., EZH2)",
    "Protein_Change": {
      "ref": "A",
      "alt": "V",
      "position": "374"
    },
    "variant_string_id": "EZH2 A374V"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper states that EZH2 mutations impair H3K27me3 deposition and disrupt PRC2 complex activity, leading to oncogenesis.",
      "judgment": "Yes",
      "reasoning": "The study clearly defines the molecular basis of EZH2 mutations in cancer pathogenesis."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Cell-based assays and biochemical assays were used to assess PRC2 function.",
      "judgment": "Yes",
      "reasoning": "The assays directly model the disease mechanism by evaluating enzyme activity and cellular effects."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "Basic controls (e.g., wild-type EZH2) and replicates were used in the experiments.",
      "judgment": "Yes",
      "reasoning": "The paper included appropriate basic controls and multiple replicates to validate the assay."
    },
    {
      "step_name": "Sub-step 3a: Basic Controls and Replicates",
      "extracted_paper_info": "Wild-type and mutant EZH2 constructs were used as controls, and experiments were performed in triplicate.",
      "judgment": "Yes",
      "reasoning": "Both normal and abnormal controls were included, and replicates were performed."
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "Known pathogenic EZH2 mutants were used as positive controls.",
      "judgment": "Yes",
      "reasoning": "Variant-specific controls were used to validate the functional assay."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "Statistical analyses showed significant differences in H3K27me3 levels between wild-type and mutant EZH2.",
      "judgment": "Yes",
      "reasoning": "The statistical analysis provided sufficient evidence to correlate the functional impact of the mutation."
    },
    {
      "step_name": "Sub-step 4c: Correlate OddsPath",
      "extracted_paper_info": "OddsPath calculation was not explicitly mentioned, but the study provided robust statistics.",
      "judgment": "Yes",
      "reasoning": "The functional evidence strength is inferred to be supporting based on the assays and controls used."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "The EZH2 A374V mutation was shown to disrupt PRC2 function in cell-based and biochemical assays, with appropriate controls and statistical support. This indicates a likely pathogenic role for the variant."
}